We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Capacity Expansion through Investment and Innovation
17 Sep 2020 - We have made considerable investments in scale capacities to satisfy the needs of our customers from early stage development to commercial production. Considering the continuous growth […]
Read moreMinimizing HCN in DIC/Oxyma-Mediated Amide Bond-Forming Reactions
15 Jun 2020 - Aiming at advancing protocols for safer, environmentally sensible peptide synthesis we report our findings with regard to the occurrence of hydrogen cyanide (HCN, prussic acid) in amide bond-forming reactions mediated by diisopropylcarbodiimide (DIC) and ethyl (hydroxyimino)cyanoacetate (Oxyma).[…]
Read morePolyPeptide Group Selected by Novavax to Manufacture Critical Intermediates of Matrix-M™ Adjuvant for its COVID-19 Vaccine
4 Jun 2020 - The PolyPeptide Group, a global Contract Development and Manufacturing Organization (CDMO) for Peptide, Peptidomimetic and other Drug Substances, has announced that it has partnered with Novavax […]
Read morePolyPeptide News Flash, #2, 2020
12 May 2020 - While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19. While the COVID-19 crisis continues, the PolyPeptide […]
Read moreInformation Letter on COVID-19
23 Apr 2020 - Our company is actively engaged in helping to find treatments and cures for COVID-19. Dear Valued Customer, While the COVID-19 crisis continues, I want to assure […]
Read moreMinimizing HCN in DIC/Oxyma-Mediated Amide Bond-Forming Reactions
16 Mar 2020 - Webinar Abstract: Diisopropylcarbodiimide (DIC) and ethyl (hydroxyimino)cyanoacetate (Oxyma) are the most widely used coupling reagents in peptide synthesis. McFarland et al. recently discovered the reaction between DIC and Oxyma, which forms hydrogen cyanide (HCN), […]
Read moreSelection of publications on significant advances in production and use of Peptides
1 Mar 2020 - We would like to share a selection of 10 publications reporting significant advances concerning production and use of Peptides, by Jan Pawlas, Ph.D. Scientist, Global Development, […]
Read moreNew member of the Medicon Valley Alliance
24 Feb 2020 - We are happy to announce that the PolyPeptide Group is now a member of the Medicon Valley Alliance (MVA), a non-profit membership organization. We are happy […]
Read morePolyPeptide News Flash February 2020
12 Feb 2020 - In 2019, we made significant progress in reducing solvent consumption. Our goal is to become the most environmentally friendly solution provider for peptides. In 2019 we […]
Read more